Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin in Women with Metabolic Syndrome
NCT01785615Phase 2Completed
- Sponsor
- University of Rochester
- Start
- Nov 2004
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in metabolic syndrome comparing Atorvastatin with Placebo (2 arms). Primary endpoints: Mean Low Density Lipoprotein Cholesterol at 6 weeks, Mean Triglycerides at 6 weeks and 15 more. Started Nov 2004; status: completed.
02
Drugs
atorvastatin
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT01785615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01785615.